ISCOMs and other saponin based adjuvants

Area of Science:

• Immunology
• Natural Products Chemistry
• Vaccine Adjuvants

Background:

• Saponins are diverse plant glycosides, including sterol and triterpene types.
• Quillaia saponins have enhanced immune responses since the 1920s, used in veterinary vaccines.
• Human vaccine development is hindered by saponin complexity and toxicity concerns.

Purpose of the Study:

• To review saponin use in animal vaccines.
• To focus on developing saponin adjuvants for human vaccines.
• To discuss advancements in saponin purification, structure-activity relationships, and formulation.

Main Methods:

• Review of existing literature on saponin applications in vaccines.
• Analysis of saponin purification techniques for defined fractions.
• Examination of structure-toxicity and structure-activity relationships.
• Investigation of novel formulations, such as ISCOMs, for reduced toxicity.

Main Results:

• Saponins demonstrate significant adjuvant properties, enhancing immune responses.
• Purification and formulation strategies are crucial for mitigating saponin toxicity.
• Understanding cellular interactions and cytokine induction provides insights into adjuvant mechanisms.

Conclusions:

• Saponin adjuvants hold promise for human vaccines.
• Further research into purified fractions and advanced formulations is essential.
• Optimizing saponin structure and formulation can lead to safer and more effective vaccine adjuvants.